PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Nephrology, Tokyo Saiseikai Central Hospital, 1-4-17 Mita, Minato-ku, Tokyo, 108-0073, Japan.\', \'Department of Nephrology, Tokyo Saiseikai Central Hospital, 1-4-17 Mita, Minato-ku, Tokyo, 108-0073, Japan. ayutsuranaide@hotmail.com.\', \'Department of Rheumatology, Keio University School of Medicine, Tokyo, Japan.\', \'Department of General Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.\', \'Department of Emergency and Critical Care Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.\', \'Department of Hematology, Tokyo Saiseikai Central Hospital, Tokyo, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s10157-021-02126-4
?:hasPublicationType
?:journal
  • Clinical and experimental nephrology
is ?:pmid of
?:pmid
?:pmid
  • 34436742
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.711
?:rankingScore_hIndex
  • 42
is ?:relation_isRelatedTo_publication of
?:title
  • Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34436742>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34436742>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all